Benzinga | Jan 5, 2022 04:53AM EST

UBS Downgrades Salesforce.com to Neutral, Lowers Price Target to $265

UBS analyst Karl Keirstead downgrades Salesforce.com (NYSE:CRM) from Buy to Neutral and lowers the price target from $315 to $265.